Myeloid cell function in MRP-14 (S100A9) null mice

被引:173
|
作者
Hobbs, JAR [1 ]
May, R [1 ]
Tanousis, K [1 ]
McNeill, E [1 ]
Mathies, M [1 ]
Gebhardt, C [1 ]
Henderson, R [1 ]
Robinson, MJ [1 ]
Hogg, N [1 ]
机构
[1] Canc Res UK, Leukocyte Adhes Lab, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England
关键词
D O I
10.1128/MCB.23.7.2564-2576.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myeloid-related protein 14 (MRP-14) and its heterodimeric partner, NIRP-8, are cytosolic calcium-binding proteins, highly expressed in neutrophils and monocytes. To understand the function of NIRP-14, we performed targeted disruption of the MRP-14 gene in mice. MRP-14(-/-) mice showed no obvious phenotype and were fertile. MRP-8 mRNA but not protein is present in the myeloid cells of these mice, suggesting that the stability of MRP-8 protein is dependent on MRP-14 expression. A compensatory increase in other proteins was not detected in cells lacking MRP-8 and MRP-14. Although the morphology of MRP-14(-/-) myeloid cells was not altered, they were significantly less dense. When Ca2+ responses were investigated, there was no change in the maximal response to the chemokine MIP-2. At lower concentrations, however, there was reduced responsiveness in MRP-14(-/-) compared with MRP-14(+/+) neutrophils. This alteration in the ability to flux Ca2+ did not impair the ability of the MRP-14(-/-) neutrophils to respond chemotactically to MIP-2. In addition, the myeloid cell functions of phagocytosis, superoxide burst, and apoptosis were unaffected in MRP-14(-/-) cells. In an in vivo model of peritonitis, MRP-14(-/-) mice showed no difference from wild-type mice in induced inflammatory response. The data indicate that MRP-14 and MR-P-8 are dispensable for many myeloid cell functions.
引用
收藏
页码:2564 / 2576
页数:13
相关论文
共 50 条
  • [41] The function of PSTPIP1 and S100A8/S100A9 in autoinflammatory diseases
    Fassl, S.
    Holzinger, D.
    Vogl, T.
    Foell, D.
    Roth, J.
    Austermann, J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 : 30 - 30
  • [42] FUNCTION OF THE S100A8 AND S100A9 PROTEIN COMPLEX IN LIVER HOMEOSTASIS AND INFLAMMATION
    Wiechert, L.
    Nemeth, J.
    Pusterla, T.
    Schoenthaler, H. B.
    Stein, I.
    Horwitz, E.
    Ben-Neriah, Y.
    Pikarsky, E.
    Wagner, E. F.
    Angel, P.
    Hess, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S131 - S131
  • [43] S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity
    Nacken, W
    Roth, J
    Sorg, C
    Kerkhoff, C
    MICROSCOPY RESEARCH AND TECHNIQUE, 2003, 60 (06) : 569 - 580
  • [44] Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation
    Arai, K
    Teratani, T
    Nozawa, R
    Yamada, T
    ONCOLOGY REPORTS, 2001, 8 (03) : 591 - 596
  • [45] A KEY ROLE OF S100A9 IN THE PATHOGENESIS OF PSORIATIC ARTHRITIS IN TTP/S100 DEFICIENT MICE
    Froehling, M.
    Vogl, T.
    Loser, K.
    Paruzel, P.
    Blackshear, P. J.
    Stumpo, D. J.
    Roth, J.
    Pap, T.
    Stratis, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A13 - A13
  • [46] Development and evaluation of a non-peptidic ligand for the molecular imaging of inflammatory processes using S100A9 (MRP14) as a novel target
    Faust, A.
    Voeller, T.
    Busch, F.
    Schaefers, M.
    Roth, J.
    Hermann, S.
    Vogl, T.
    CHEMICAL COMMUNICATIONS, 2015, 51 (86) : 15637 - 15640
  • [47] Chemotactic activity of S100A8 and S100A9
    Roth, J
    Vogl, T
    Sunderkötter, C
    Sorg, C
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5651 - 5651
  • [48] S100A8 and S100A9 in experimental osteoarthritis
    Zreiqat, Hala
    Belluoccio, Daniele
    Smith, Margaret M.
    Wilson, Richard
    Rowley, Lynn A.
    Jones, Katie
    Ramaswamy, Yogambha
    Vogl, Thomas
    Roth, Johannes
    Bateman, John F.
    Little, Christopher B.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)
  • [49] S100A8 and S100A9 in inflammation and cancer
    Gebhardt, Christoffer
    Nemeth, Julia
    Angel, Peter
    Hess, Jochen
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1622 - 1631
  • [50] S100A8 and S100A9 in inflammatory diseases
    Roth, J
    Goebeler, M
    Sorg, C
    LANCET, 2001, 357 (9261): : 1041 - 1041